Taking a broad and long-term view to establish China Center for Evidence Based Traditional Chinese Medicine (CCEBTCM)_Chinese Journal of Evidence-Based Medicine

Authors：

WANG Yongyan , HUANG Luqi

China Academy of Chinese Medical Sciences, Beijing, 100700, P.R.China;

Corresponding author：

Keywords：

China Center for Evidence Based Traditional Chinese Medicine (CCEBTCM); Traditional Chinese medicine; Evidence-based medicine; Inheritance and innovation; Research teams resource integration; Development consensus

DOI：

10.7507/1672-2531.201908098

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Clinical efficacy evaluation is important for the development of traditional Chinese medicine (TCM). In view of the existing accumulation and current situation of the TCM clinical efficacy evaluation, based on the international perspective, and taking the rational and objective evaluation of TCM clinical efficacy and safety as the foundation, in order to enhance TCM evidence level to support clinical decision-making and promote TCM industry and TCM internationalization development, the State Administration of TCM entrusted China Academy of Chinese Medical Sciences to establish China Center for Evidence Based Traditional Chinese Medicine (CCEBTCM). CCEBTCM is expected to optimize the allocation of evidence-based research resources in TCM field to further integrate advantages of evidence-based TCM research teams, promote consensus on evidence-based TCM standards, share evidence-based TCM data or information and lead cultural exchanges between Chinese and overseas. In this way, the status and influence of TCM in the world will be enhanced so that it can better serve global health.

Citation： WANG Yongyan, HUANG Luqi. Taking a broad and long-term view to establish China Center for Evidence Based Traditional Chinese Medicine (CCEBTCM). Chinese Journal of Evidence-Based Medicine, 2019, 19(10): 1131-1137. doi: 10.7507/1672-2531.201908098 Copy

1.	Spriet A, Simon P, Dupin-Spriet T. Methodology of clinical drug trials. New York: Karger, 1985: 14-15.
2.	青蒿素结构研究协作组. 一种新型的倍半萜内酯—青蒿素. 科学通报, 1977, 22(3): 142.
3.	Hesketh T, Zhu WX. Traditional Chinese medicine: one country, two systems. BMJ, 1997, 315(7100): 115-117.
4.	陈可冀, 钱振淮, 张问渠, 等. 精制冠心片双盲法治疗冠心病心绞痛 112 例疗效分析. 中华心血管病杂志, 1982, 10(2): 85-89.
5.	Tang JL, Zhan SY, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ, 1999, 319(7203): 160-161.
6.	李幼平, 李静, 孙鑫, 等. 循证医学在中国的起源与发展: 献给中国循证医学20周年. 中国循证医学杂志, 2016, 16(1): 2-6.
7.	王永炎, 刘保延, 谢雁鸣. 应用循证医学方法构建中医临床评价体系. 中国中医基础医学杂志, 2003, 9(3): 17-23.
8.	陈可冀, 宋军. 循证医学的提出对中西医结合的启发. 中国中西医结合杂志, 1999, 19(11): 643.
9.	张伯礼. 辨证论治与循证医学. 中国循证医学杂志, 2002, 2(1): 1-3.
10.	李幼平, 刘鸣. 循证医学与中医药现代化. 中国中医药信息杂志, 1999, 8(12): 14-16, 32.
11.	张晓雨, 陈诗琪, 李承羽, 等. 循证中医药学理论研究与应用实践. 中国循证医学杂志, 2018, 18(1): 86-91.
12.	Shang H, Zhang J, Yao C, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med, 2013, 2013: 1-9.
13.	刘建平. 循证医学. 人民卫生出版社, 2012.
14.	刘建平, 商洪才. 循证中医药. 人民卫生出版社, 2018.
15.	Zhang X, Tian R, Yang Z, et al. Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries. BMJ Open, 2019, 9(2): e025218.
16.	Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med, 2017, 167(2): W7-W20.
17.	Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA, 2017, 317(24): 2493-2501.
18.	Zhao L, Chen J, Li Y, et al. The long-term effect of acupuncture for migraine prophylaxis: a randomized clinical trial. JAMA Intern Med, 2017, 177(4): 508-515.
19.	Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med, 2016, 165(11): 761-769.
20.	Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza. Ann Intern Med, 2011, 155(4): 217-225.
21.	Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin Capsules in patients with chronic heart failure. J Am Coll Cardiol, 2013, 62(12): 1065-1072.
22.	Lu Z, Kou W, Du B, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol, 2008, 101(12): 1689-1693.
23.	Song Y, Yao C, Yao Y, et al. XueBiJing injection versus placebo for critically Ⅲ patients with severe community-acquired pneumonia: a randomized controlled trial. Crite Care Med,, 2019, 47(9): e735-e743.
24.	王忠, 王永炎. 中药上市后临床再评价研究. 中国中药杂志, 2007, 32(1): 84-86.
25.	杨薇, 谢雁鸣, 王永炎. 中医药临床实效研究—中药注射剂注册登记式医院集中监测方案解读. 中国中药杂志, 2012, 37(18): 2683-2685.
26.	赵晨, 田贵华, 王燕平, 等. 涵盖科学观与人文观的循证医学发展—兼谈循证中医药学科的未来前景. 中国循证医学杂志, 2019, 19(2): 232-237.
27.	Ahn K. The worldwide trend of using botanical drugs and strategies for developing global drugs. BMB Rep, 2017, 50(3): 111-116.
28.	杨瑾, 加茂智嗣, 能濑爱加. 汉方药在日本的发展现状. 中草药, 2016, 47(15): 2771-2774.
29.	中华中医药学会. 中医药重大科学问题和工程技术难题. 中医杂志, 2019, 60(12): 991-1000.

1. Spriet A, Simon P, Dupin-Spriet T. Methodology of clinical drug trials. New York: Karger, 1985: 14-15.
2. 青蒿素结构研究协作组. 一种新型的倍半萜内酯—青蒿素. 科学通报, 1977, 22(3): 142.
3. Hesketh T, Zhu WX. Traditional Chinese medicine: one country, two systems. BMJ, 1997, 315(7100): 115-117.
4. 陈可冀, 钱振淮, 张问渠, 等. 精制冠心片双盲法治疗冠心病心绞痛 112 例疗效分析. 中华心血管病杂志, 1982, 10(2): 85-89.
5. Tang JL, Zhan SY, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ, 1999, 319(7203): 160-161.
6. 李幼平, 李静, 孙鑫, 等. 循证医学在中国的起源与发展: 献给中国循证医学20周年. 中国循证医学杂志, 2016, 16(1): 2-6.
7. 王永炎, 刘保延, 谢雁鸣. 应用循证医学方法构建中医临床评价体系. 中国中医基础医学杂志, 2003, 9(3): 17-23.
8. 陈可冀, 宋军. 循证医学的提出对中西医结合的启发. 中国中西医结合杂志, 1999, 19(11): 643.
9. 张伯礼. 辨证论治与循证医学. 中国循证医学杂志, 2002, 2(1): 1-3.
10. 李幼平, 刘鸣. 循证医学与中医药现代化. 中国中医药信息杂志, 1999, 8(12): 14-16, 32.
11. 张晓雨, 陈诗琪, 李承羽, 等. 循证中医药学理论研究与应用实践. 中国循证医学杂志, 2018, 18(1): 86-91.
12. Shang H, Zhang J, Yao C, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med, 2013, 2013: 1-9.
13. 刘建平. 循证医学. 人民卫生出版社, 2012.
14. 刘建平, 商洪才. 循证中医药. 人民卫生出版社, 2018.
15. Zhang X, Tian R, Yang Z, et al. Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries. BMJ Open, 2019, 9(2): e025218.
16. Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med, 2017, 167(2): W7-W20.
17. Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA, 2017, 317(24): 2493-2501.
18. Zhao L, Chen J, Li Y, et al. The long-term effect of acupuncture for migraine prophylaxis: a randomized clinical trial. JAMA Intern Med, 2017, 177(4): 508-515.
19. Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med, 2016, 165(11): 761-769.
20. Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza. Ann Intern Med, 2011, 155(4): 217-225.
21. Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin Capsules in patients with chronic heart failure. J Am Coll Cardiol, 2013, 62(12): 1065-1072.
22. Lu Z, Kou W, Du B, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol, 2008, 101(12): 1689-1693.
23. Song Y, Yao C, Yao Y, et al. XueBiJing injection versus placebo for critically Ⅲ patients with severe community-acquired pneumonia: a randomized controlled trial. Crite Care Med,, 2019, 47(9): e735-e743.
24. 王忠, 王永炎. 中药上市后临床再评价研究. 中国中药杂志, 2007, 32(1): 84-86.
25. 杨薇, 谢雁鸣, 王永炎. 中医药临床实效研究—中药注射剂注册登记式医院集中监测方案解读. 中国中药杂志, 2012, 37(18): 2683-2685.
26. 赵晨, 田贵华, 王燕平, 等. 涵盖科学观与人文观的循证医学发展—兼谈循证中医药学科的未来前景. 中国循证医学杂志, 2019, 19(2): 232-237.
27. Ahn K. The worldwide trend of using botanical drugs and strategies for developing global drugs. BMB Rep, 2017, 50(3): 111-116.
28. 杨瑾, 加茂智嗣, 能濑爱加. 汉方药在日本的发展现状. 中草药, 2016, 47(15): 2771-2774.
29. 中华中医药学会. 中医药重大科学问题和工程技术难题. 中医杂志, 2019, 60(12): 991-1000.

Next Article
Translation and interpretation of the European guideline on management of major bleeding and coagulopathy following trauma (the fifth edition)

Chinese Journal of Evidence-Based Medicine

Taking a broad and long-term view to establish China Center for Evidence Based Traditional Chinese Medicine (CCEBTCM)

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content